Estimated medical cost reductions associated with apixaban in real-world patients with non-valvular atrial fibrillation

Author： Amin Alpesh   Stokes Michael   Wu Ning   Gatt Elyse   Makenbaeva Dinara   Wiederkehr Daniel   Boulanger Luke  

Publisher： Informa Healthcare

ISSN： 1369-6998

Source： Journal of Medical Economics, Vol.16, Iss.10, 2013-10, pp. : 1193-1202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Application of randomized clinical trial data to actual practice: apixaban therapy for reduction of stroke risk in non-valvular atrial fibrillation patients

By Amin Alpesh   Stokes Michael   Wu Ning   Gatt Elyse   Makenbaeva Dinara   Wiederkehr Daniel   Boulanger Luke  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1253-1261

Informa Healthcare

Access to resources Recommend Favorite

Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation?

By Laliberté François   Pilon Dominic   Raut Monika K.   Nelson Winnie W.   Olson William H.   Germain Guillaume   Schein Jeff R.   Lefebvre Patrick  

Current Medical Research and Opinion, Vol. 30, Iss. 4, 2014-04 ,pp. : 645-653

Informa Healthcare

Access to resources Recommend Favorite

Characteristics of patients with non-valvular atrial fibrillation using dabigatran or warfarin in the US

By Schoof Nils   Schnee Janet   Schneider Gary   Gawlik Melissa   Zint Kristina   Clemens Andreas   Bartels Dorothee B.  

Current Medical Research and Opinion, Vol. 30, Iss. 5, 2014-05 ,pp. : 795-804

Informa Healthcare

Access to resources Recommend Favorite

Medical costs in the US of clinical events associated with oral anticoagulant (OAC) use compared to warfarin among non-valvular atrial fibrillation patients ≥75 and <75 years of age, based on the ARISTOTLE, RE-LY, and ROCKET-AF trials

By Deitelzweig Steve   Amin Alpesh   Jing Yonghua   Makenbaeva Dinara   Wiederkehr Daniel   Lin Jay   Graham John  

Journal of Medical Economics, Vol. 16, Iss. 9, 2013-09 ,pp. : 1163-1168

Informa Healthcare

Access to resources Recommend Favorite

Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system

By Darkow Theodore   Vanderplas Ann M.   Lew Kim H.   Kim Jennifer   Hauch Ole  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1583-1594

Informa Healthcare

Access to resources Recommend Favorite